Asthma Clinical Trials in New York

23 recruiting studies across 1 city

Browse by City

All Trials in New York

Phase

Trial	Phase	Sponsor	Dist.
Individualizing Treatment for Asthma in Primary Care (Full Study)	Phase 4	DARTNet Institute	<1 mi
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study	Phase 3	GlaxoSmithKline	<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	<1 mi
Allergy and Immunology Natural History Study	—	Columbia University	<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma	Phase 2	Eli Lilly and Company	<1 mi
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma	Phase 2	Incyte Corporation	<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Asthma Symptom Perception Study	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Biologics And Clinical Immunology Cohort at Sinai	—	Icahn School of Medicine at Mount Sinai	<1 mi
Protocol CAUSE-03 / CHEETAH	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma	Phase 2	Sanofi	<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	4 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment	Phase 3	AstraZeneca	5 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids	Phase 2	AstraZeneca	5 mi
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma	N/A	Columbia University	5 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)	Phase 3	AstraZeneca	12 mi
ASTHMAXcel Voice Study	N/A	Montefiore Medical Center	12 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma	Phase 3	GlaxoSmithKline	12 mi
Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools	N/A	Montefiore Medical Center	12 mi
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations	—	Aevice Health Pte. Ltd.	12 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma	Phase 3	AstraZeneca	13 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma	Phase 2	Pfizer	25 mi
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)	Phase 3	Sanofi	29 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.